scispace - formally typeset
Open AccessJournal ArticleDOI

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Reads0
Chats0
TLDR
A machine-learning technique—Subtype and Stage Inference (SuStaIn)—able to uncover data-driven disease phenotypes with distinct temporal progression patterns, from widely available cross-sectional patient studies is introduced, using two neurodegenerative disease cohorts.
Abstract
The heterogeneity of neurodegenerative diseases is a key confound to disease understanding and treatment development, as study cohorts typically include multiple phenotypes on distinct disease trajectories. Here we introduce a machine-learning technique-Subtype and Stage Inference (SuStaIn)-able to uncover data-driven disease phenotypes with distinct temporal progression patterns, from widely available cross-sectional patient studies. Results from imaging studies in two neurodegenerative diseases reveal subgroups and their distinct trajectories of regional neurodegeneration. In genetic frontotemporal dementia, SuStaIn identifies genotypes from imaging alone, validating its ability to identify subtypes; further the technique reveals within-genotype heterogeneity. In Alzheimer's disease, SuStaIn uncovers three subtypes, uniquely characterising their temporal complexity. SuStaIn provides fine-grained patient stratification, which substantially enhances the ability to predict conversion between diagnostic categories over standard models that ignore subtype (p = 7.18 × 10-4) or temporal stage (p = 3.96 × 10-5). SuStaIn offers new promise for enabling disease subtype discovery and precision medicine.

read more

Content maybe subject to copyright    Report

Citations
More filters
Book ChapterDOI

Prospective Cohort Study

Journal ArticleDOI

An update on genetic frontotemporal dementia.

TL;DR: Increased knowledge about genetic FTD has led to more clinical presymptomatic genetic testing but this has not yet been mirrored in the development of either an accepted FTD-specific testing protocol or provision of appropriate psychological support mechanisms for those living through the at-risk phase.
Journal Article

TMEM106B is a Genetic Modifier of Frontotemporal Lobar Degeneration with C9orf72 Hexanucleotide Repeat Expansions (P2.150)

TL;DR: Chen et al. as mentioned in this paper evaluated TMEM106B as a genetic modifier in C9orf72-associated frontotemporal lobar degeneration (FTLD)-associated TAR DNA binding protein of 43kDa.
Journal ArticleDOI

NODDI in clinical research.

TL;DR: The applications of NODDI in clinical research are reviewed and future perspectives for investigations toward the implementation of dMRI microstructure imaging in clinical practice are discussed.
References
More filters
Book ChapterDOI

Prospective Cohort Study

Related Papers (5)